An arrhythmia—an abnormal heart rhythm, or irregular heartbeat—in a child can be treated in many cases with a technique called a catheter ablation. When catheter ablation fails or when the patient also has a congenital heart condition (he or she is born with it), it may be necessary to perform surgery to ablate (remove) the arrhythmia.
An arrhythmia—an abnormal heart rhythm, or irregular heartbeat—in a child can be treated in many cases with a technique called a catheter ablation. During a catheter ablation, a high-frequency electrical energy is delivered through a catheter (a small, thin tube) to a small area inside the heart that causes the abnormal heart rhythm. (The catheter is placed through a vein in the leg and advanced into the heart.) In this way, the abnormal electrical pathway that is causing the arrhythmia is removed.
When catheter ablation fails or when the patient also has a congenital heart condition (he or she is born with it), it may be necessary to perform surgery to ablate (remove) the arrhythmia. In the case of congenital heart disease, surgical ablation can be done at the same time as surgery to correct the heart defect.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Arrhythmias can start in either the atria (the heart’s two upper chambers) or in the ventricles (the two lower, or pumping, chambers). Procedures can be performed for different types of arrhythmias, including:
Some patients with SVT have what is called an accessory pathway, which is an abnormal muscle located between the atria and ventricles. Patients with accessory pathways may also have Wolff-Parkinson-White syndrome, which is a form of SVT in which abnormal electrical signals can re-enter the heart through the accessory pathway. This can cause dangerous arrhythmias that can increase the chances of sudden death.
In childhood, accessory connection-mediated tachycardia accounts for at least 80% of SVT. The goal of catheter ablation for Wolff-Parkinson-White syndrome is to ablate accessory connections that are responsible for the re-entry of the electrical signal and the tachycardia.
A surgery called the Maze procedure was developed to ablate atrial fibrillation. In the Maze procedure, several incisions or lesions are created in the right and left atria in order to form scar tissue that blocks the chaotic electrical impulses from entering the heart. As a result, the electrical impulses are channeled into a single path to the atrioventricular (AV) node, as normal, to allow the atrium to contract uniformly. The AV node then sends the signal to the ventricles, causing them to contract.
Almost all of these surgical approaches include removal of the left atrial appendage, a small, ear-shaped flap of tissue located in the left atrium. The left atrial appendage is a potential source of blood clots in patients who have atrial fibrillation.
Advantages of the Maze procedure in patients who have atrial fibrillation are reduced risks of stroke, blood clots, and hemorrhage.
The traditional surgical Maze procedure is known as the "cut and sew Maze" because it relies on surgical incisions. It is difficult to perform and requires that the heart be stopped for 45 to 60 minutes, during which time a heart-lung machine is used to circulate blood.
Instead of cutting into the wall of the atria, newer techniques to perform Maze surgery use such techniques as radiofrequency, microwave, laser, ultrasound, or cryoablation (freezing). The Cox-Maze III procedure, for example, is a less invasive Maze procedure that uses a bipolar radiofrequency energy. It takes less time to perform than the traditional "cut and sew" Maze procedure.
In patients with atrial fibrillation who also have certain forms of structural heart disease, a modified Maze procedure using cryoablation lesions in addition to surgical lesions is effective at blocking abnormal electrical impulses from re-entering the heart.
Treatment options for ventricular tachycardia are more limited. Implantable defibrillators have been shown to prevent sudden cardiac death caused by ventricular tachycardia and fibrillation. An implantable defibrillator is an electronic device that constantly checks the patient’s heart rhythm. When it detects a very fast, abnormal heart rhythm, it delivers energy to the heart muscle, allowing the heart to beat in a normal rhythm again.
In children, pacemakers are sometimes implanted when a congenital heart defect is repaired and the patient has ventricular arrhythmias. It may also be used in cases in which the child has ventricular arrhythmias and a strong family history of sudden death.
Almost 90% of patients who have atrial arrhythmias who undergo ablation have their normal heart rhythm restored and remain free of arrhythmia at 10 years. The mini-Maze procedure has had similar success in eliminating atrial fibrillation, but because these procedures are newer, long-term follow-up is lacking.
Ablation of ventricular arrhythmias is less successful (50% to 70% at 10 years). In the case of ventricular tachycardia in patients who also have congenital heart disease, the patient may also need to have a defibrillator implanted to correct the heart rhythm.
The hospital stay for patients who have surgery is typically 5 to 7 days; for patients who have catheter ablation, the stay is one day.
The patient may have some chest pain and fatigue for up to 2 months. Recovery is usually complete in 6 months.
Last reviewed by a Cleveland Clinic medical professional on 04/27/2011.
Learn more about our editorial process.